Connection

Inderjit Singh to Biomarkers

This is a "connection" page, showing publications Inderjit Singh has written about Biomarkers.
Connection Strength

0.367
  1. Combination therapy of lovastatin and AMP-activated protein kinase activator improves mitochondrial and peroxisomal functions and clinical disease in experimental autoimmune encephalomyelitis model. Immunology. 2018 07; 154(3):434-451.
    View in: PubMed
    Score: 0.100
  2. MicroRNA Profiling Identifies miR-196a as Differentially Expressed in Childhood Adrenoleukodystrophy and Adult Adrenomyeloneuropathy. Mol Neurobiol. 2017 03; 54(2):1392-1403.
    View in: PubMed
    Score: 0.087
  3. Functional Characterization of IPSC-Derived Brain Cells as a Model for X-Linked Adrenoleukodystrophy. PLoS One. 2015; 10(11):e0143238.
    View in: PubMed
    Score: 0.086
  4. Molecular organization of peroxisomal enzymes: protein-protein interactions in the membrane and in the matrix. Arch Biochem Biophys. 2006 Jul 15; 451(2):128-40.
    View in: PubMed
    Score: 0.044
  5. Emerging Markers of Early Brain Injury and Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage. World Neurosurg. 2017 Nov; 107:148-159.
    View in: PubMed
    Score: 0.024
  6. Effect of clofibrate on peroxisomal lignoceroyl-CoA ligase activity. Biochem Med Metab Biol. 1990 Feb; 43(1):22-9.
    View in: PubMed
    Score: 0.014
  7. Caffeic acid phenethyl ester reduces neurovascular inflammation and protects rat brain following transient focal cerebral ischemia. J Neurochem. 2007 Jul; 102(2):365-77.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.